|
|
ZAMRA-HM-26-48
|
Kadcyla
|
trastuzumab emtansine
|
F.Hoffmann La Roche
|
Registered/Compliant
|
Details →
|
|
|
ZAMRA-HM-26-18
|
kadcyla
|
trastuzumab emtansine
|
Roche Products
|
Registered/Compliant
|
Details →
|
|
|
ZAMRA-HM-26-52
|
SEZUMA 150
|
Trastuzumab 150 mg
|
Hetero Biopharma Limited
|
Registered/Compliant
|
Details →
|
|
|
ZAMRA-HM-26-51
|
SEZUMA 440
|
Trastuzumab 440 mg
|
Hetero Biopharma Limited
|
Registered/Compliant
|
Details →
|
|
|
014/055
|
HERTRAZ 440
|
Trastuzumab 440 mg
|
Mylan Laboratories Limited
|
Registered/Compliant
|
Details →
|
|
|
014/054
|
Hertraz 150 infusion
|
Trastuzumab 150 mg
|
Mylan Laboratories Ltd
|
Registered/Compliant
|
Details →
|
|
|
ZAMRA-HM-25-80
|
TrastuRel™ 150mg for Injection
|
Trastuzumab 150 mg
|
Reliance Life Sciences Pvt. Ltd
|
Registered/Compliant
|
Details →
|
|
|
ZAMRA-HM-25-89
|
TrastuRel™ 440 Lyophilised Powder for I.V Injection
|
Trastuzumab 440 mg 440mg mg
|
Reliance Life Sciences Pvt. Ltd
|
Registered/Compliant
|
Details →
|
|
|
ZAMRA-HM-23-32
|
Phesgo 1200/600 mg solution for subcutaneous injection
|
Pertuzumab 1200 mg,Trastuzumab 600 mg
|
Roche Products (Pty) Ltd
|
Registered/Compliant
|
Details →
|
|
|
ZAMRA-HM-23-31
|
Phesgo 600/600 mg solution for subcutaneous injection
|
Pertuzumab 600 mg,Trastuzumab 600 mg
|
Roche Products (Pty) Ltd
|
Registered/Compliant
|
Details →
|